Skip to content
← Holders

RA Capital Management, L.P.

What RA Capital Management, L.P. reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 1346824 · Filed Nov 16, 2026

Positions
92
Reported value
$10B
Opened
21
Closed
13
Other managers included
0

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Sep 30, 2025$8.1B
    67 positions
  2. Dec 31, 2025$9.8B
    71 positions
  3. Mar 31, 2026$9.4B
    85 positions
  4. Jun 30, 2026$11.5B
    84 positions
  5. Sep 30, 2026$10B
    92 positions
SecuritySharesChangeValueOf portfolio
ASNDAscendis Pharma A/S
10.3M±0%$2.3B23.5%
PBLSParabilis Medicines, Inc.
29.2M+0.8%$942.2M9.5%
PCVXVaxcyte, Inc.
11.5M±0%$652.9M6.5%
RYTMRhythm Pharmaceuticals, Inc.
6.7M±0%$634.8M6.4%
EWTXEdgewise Therapeutics, Inc.
8.4M±0%$340.7M3.4%
TYRATyra Biosciences, Inc.
12.2M±0%$266.8M2.7%
FRNMFreenome, Inc.
15.4MNew$242M2.4%
COAGHemab Therapeutics Holdings, Inc.
7.8M±0%$240.8M2.4%
NAMSNewAmsterdam Pharma Co N.V.
9.6M±0%$232.3M2.3%
SEPNSepterna, Inc.
5.5M−21.3%$215.3M2.2%
SGPSpyGlass Pharma, Inc.
8M±0%$208.5M2.1%
JANXJanux Therapeutics, Inc.
11.2M±0%$193.4M1.9%
MLYSMineralys Therapeutics, Inc.
7.7M±0%$193.3M1.9%
IRONDisc Medicine, Inc.
2.5M±0%$160.4M1.6%
TSHATaysha Gene Therapies, Inc.
30.4M+29.2%$148.2M1.5%
BCAXBicara Therapeutics Inc.
7.3M±0%$135M1.4%
ARTVArtiva Biotherapeutics, Inc.
18.5M+3.0%$131.6M1.3%
XNCRXencor Inc
5.3M±0%$131.6M1.3%
ORKAOruka Therapeutics, Inc.
1.6M±0%$129.5M1.3%
AMLXAmylyx Pharmaceuticals, Inc.
4.3MNew$124.5M1.2%
CLYMClimb Bio, Inc.
10.1M−10.4%$116.2M1.2%
ABVXAbivax S.A.
1M−9.1%$102M1%
WVEWave Life Sciences, Inc.
27MNew$99.8M1%
LTGOLatigo Biotherapeutics, Inc.
5.3MNew$88.6M0.9%
SLDBSolid Biosciences Inc.
12M±0%$87M0.9%
VORVor Biopharma Inc.
4.5M+87.5%$85.9M0.9%
LBRXLB Pharmaceuticals Inc
2.2M±0%$84.8M0.9%
GHRSGH Research PLC
3.6M−52.7%$84.7M0.9%
OBXObsidian Therapeutics, Inc.
6MNew$81.8M0.8%
ZLABZai Lab Ltd
2.8M−51.0%$74.2M0.7%
FDMT4D Molecular Therapeutics, Inc.
5M±0%$72.3M0.7%
ACRSAclaris Therapeutics, Inc.
12.7M±0%$66.9M0.7%
SANASana Biotechnology, Inc.
18.8M±0%$54.7M0.5%
MNPRMonopar Therapeutics
667.2K±0%$53.2M0.5%
GERNGeron Corp
42.8M−0.1%$52.6M0.5%
DMRADamora Therapeutics, Inc.
2.4MNew$51.1M0.5%
PEPGPepGen Inc.
20.1M±0%$48.6M0.5%
SPRYARS Pharmaceuticals, Inc.
10.9M±0%$46.8M0.5%
ABOSAcumen Pharmaceuticals, Inc.
21M±0%$46.6M0.5%
DBVTDBV Technologies S.A.
3.7MNew$43M0.4%
AGENAgenus Inc
4.1MNew$40.9M0.4%
RZLTRezolute, Inc.
9.4M±0%$39.1M0.4%
SIONSionna Therapeutics, Inc.
6.5M−34.8%$34M0.3%
SCTXScribe Therapeutics, Inc.
1.8MNew$33.2M0.3%
IPSCCentury Therapeutics, Inc.
17.8M±0%$30.4M0.3%
EVMNEvommune, Inc.
3.5M±0%$28.9M0.3%
KRSAKorsana Biosciences, Inc.
892.7KNew$28.6M0.3%
CAPRCapricor Therapeutics, Inc.
3M+99.9%$28.5M0.3%
NKTXNkarta, Inc.
10.8M±0%$28.3M0.3%
CCCCC4 Therapeutics, Inc.
8.2M+2.4%$27.3M0.3%
JBIOJade Biosciences, Inc.
1.8M−50.0%$25.8M0.3%
PRLDPrelude Therapeutics Inc
6.5M±0%$25.3M0.3%
ACRVAcrivon Therapeutics, Inc.
12.2M±0%$25.1M0.3%
ASMBAssembly Biosciences, Inc.
1M±0%$24M0.2%
EDITEditas Medicine, Inc.
8.9M±0%$22.8M0.2%
QTTBQ32 Bio Inc.
2.3M±0%$19.3M0.2%
AVRAnteris Technologies Global Corp.
2.5M−17.5%$19.2M0.2%
ETRAElectra Therapeutics, Inc.
1.7MNew$19M0.2%
ALTAltimmune, Inc.
6.5M±0%$18.6M0.2%
BNTCBenitec Biopharma Inc.
1.9M±0%$18.5M0.2%
ALXOALX Oncology Holdings Inc
13M±0%$18.1M0.2%
SGMTSagimet Biosciences Inc.
1.8MNew$17.8M0.2%
LXEOLexeo Therapeutics, Inc.
5M±0%$16.9M0.2%
LENZLENZ Therapeutics, Inc.
4.2M±0%$16M0.2%
AURAAura Biosciences, Inc.
2.5M±0%$15.7M0.2%
AVTXAvalo Therapeutics, Inc.
1M±0%$15.3M0.2%
IKTInhibikase Therapeutics, Inc.
7MNew$14.3M0.1%
ENTXEntera Bio Ltd.
4.9MNew$14.3M0.1%
SPTXSeaport Therapeutics, Inc.
700K±0%$14.1M0.1%
SABSSAB Biotherapeutics, Inc.
4.4M±0%$14M0.1%
OVIDOvid Therapeutics Inc.
5.6M−46.7%$13.9M0.1%
MIRMMirum Pharmaceuticals, Inc.
159.3K−50.0%$13.6M0.1%
HLXCHelix Acquisition Corp. III
1.3M±0%$13.3M0.1%
DRUGBright Minds Biosciences Inc.
265K±0%$13.2M0.1%
CRBPCorbus Pharmaceuticals Holdings, Inc.
1.9MNew$13.1M0.1%
BRVEBraveheart Bio, Inc.
565KNew$11.4M0.1%
OKUROnKure Therapeutics, Inc.
4M±0%$10.9M0.1%
PALIPalisade Bio, Inc.
7.1M±0%$9.6M0.1%
INOInovio Pharmaceuticals, Inc.
7.2MNew$8.8M0.1%
MGNXMacrogenics Inc
1.9M±0%$7.2M0.1%
RANIRani Therapeutics Holdings, Inc.
8.5M±0%$6.7M0.1%
ACETAdicet Bio, Inc.
932.6K±0%$6.7M0.1%
TCGXTCGX Acquisition Corp.
500KNew$6.3M0.1%
FTHFaeth Therapeutics, Inc.
205.1K−71.6%$6.1M0.1%
JATTJATT II Acquisition Corp.
500K±0%$5.6M0.1%
JTTTJATT III Acquisition Corp
450KNew$5M0.1%
NAMSWNewAmsterdam Pharma Co N.V.
333.3K±0%$4.2M0.1%
AMANAmanat Acquisition Corp.
375K±0%$4M0.1%
EQEquillium, Inc.
2.3M−25.1%$3.8M0.1%
STROSutro Biopharma, Inc.
210.9KNew$3.4M0.1%
STOKStoke Therapeutics, Inc.
73.6KNew$1.9M0.1%
PTNPalatin Technologies Inc
62.1K±0%$551K0.1%